Filer Snapshot

Oaktree Acquisition Corp. III Life Sciences SEC EDGAR Filings

SEC filings, ownership reports, and insider transactions for CIK 0002029769.

Entity Type

Company

Total Filings

52

Latest Filing

26 Mar 2026

Industry

Blank Checks

Save this filer page for the next filing cycle

Keep this page in your research queue, then return to compare new filings with prior context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.

Best next steps

Start with the latest filings table, then open the strongest context page for this filer.

  • Use the filings table to verify the newest submission, form type, and report period.
  • Open the deeper context page only when this filer actually has insider or ownership signal.
Source: SEC filing 10-K

10-K filed on 26 Mar 2026 for CIK 0002029769.

View Source Filing
Symbol
OACC, OACCU, OACCW on Nasdaq
Business address
333 South Grand Avenue, 28 Th Floor, Los Angeles, CA, 90071
State of incorporation
Cayman Islands
Fiscal year end
31 December

Quick Takeaways

  • Oaktree Acquisition Corp. III Life Sciences is an SEC filer tracked under CIK 0002029769.
  • 52 filings are listed on this profile.
  • Common form coverage includes 10-K, SCHEDULE 13G/A, 10-Q and more.

What Changed

  • Latest filing: 10-K filed on 26 Mar 2026.
  • Report period: 31 Dec 2025.

Why This Matters

  • You can quote filing dates and form types directly from the SEC record on this page.
  • Use this profile before deeper ownership or insider analysis to confirm filing history context.

Source Evidence

Source: SEC filing 10-K

10-K filed on 26 Mar 2026 for CIK 0002029769.

View Source Filing

Return Loop

Why revisit this filer page

A newly filed 10-K can change the filing history, ownership context, or next research path for Oaktree Acquisition Corp. III Life Sciences.

Latest source-backed update
10-K filed 26 Mar 2026
Why come back
Revisit after a new SEC filing appears to compare the updated record with prior filings.
  • Latest filing on record: 10-K filed 26 Mar 2026.
  • Save this filer if you want a stable place to return after the next filing cycle.
  • Open the latest filing table or ownership context to verify what changed.

Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.

Latest update

What changed recently for Oaktree Acquisition Corp. III Life Sciences

New fact period available

Latest financial period: Q4 2025. Open the source-backed page to inspect the fresh filing or facts context.

Update date

26 Mar 2026

Page type

Company facts

Latest period

Q4 2025

SEC-backed company facts were refreshed from filings filed on 26 Mar 2026.

Benchmark Context

Benchmark context for this company

Oaktree Acquisition Corp. III Life Sciences has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest financial period: Q4 2025. That gives you a fresh baseline before you compare this company with peers.

  • Latest company facts filing date: 26 Mar 2026.
  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Filer Overview

Oaktree Acquisition Corp. III Life Sciences has filed 52 SEC EDGAR filings since 07 Aug 2024. Common forms include 10-K, SCHEDULE 13G/A, 10-Q, 3 and more.

Latest Filings

Recent SEC filings for Oaktree Acquisition Corp. III Life Sciences with direct links to document and filing folders.

Form type Document Filing Description Filing date Reporting date File number(s)
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K 10-K 26 Mar 2026 31 Dec 2025 001-42383
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 11 Feb 2026 005-94673
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 13 Nov 2025 30 Sep 2025 001-42383
3 Open 3 document View SEC filing for 3 3 29 Oct 2025 29 Oct 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 29 Oct 2025 29 Oct 2025 001-42383
3 Open 3 document View SEC filing for 3 3 22 Oct 2025 17 Oct 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 17 Oct 2025 17 Oct 2025 001-42383
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 12 Aug 2025 005-94673
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 12 Aug 2025 30 Jun 2025 001-42383
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 15 Jul 2025 005-94673
3 Open 3 document View SEC filing for 3 3 16 Jun 2025 03 Jun 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 06 Jun 2025 03 Jun 2025 001-42383
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 14 May 2025 31 Mar 2025 001-42383
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 14 May 2025 005-94673
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 14 May 2025 005-94673
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 13 May 2025 005-94673
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 09 May 2025 005-94673
10-K Open 10-K document View SEC filing for 10-K 10-K 27 Mar 2025 31 Dec 2024 001-42383
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 14 Feb 2025 005-94673
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 12 Feb 2025 005-94673
8-K Open 8-K document View SEC filing for 8-K 8-K 07 Jan 2025 06 Jan 2025 001-42383
8-K Open 8-K document View SEC filing for 8-K 8-K 11 Dec 2024 11 Dec 2024 001-42383
SC 13G Open SC 13G document View SEC filing for SC 13G AQR CAPITAL MANAGEMENT LLC 07 Nov 2024 005-94673
8-K Open 8-K document View SEC filing for 8-K 8-K 05 Nov 2024 30 Oct 2024 001-42383
4 Open 4 document View SEC filing for 4 4 31 Oct 2024 30 Oct 2024
8-K Open 8-K document View SEC filing for 8-K 8-K 31 Oct 2024 25 Oct 2024 001-42383
SC 13G Open SC 13G document View SEC filing for SC 13G 30 Oct 2024 005-94673
8-K Open 8-K document View SEC filing for 8-K 8-K 25 Oct 2024 23 Oct 2024 001-42383
424B4 Open 424B4 document View SEC filing for 424B4 424B4 24 Oct 2024 333-282508
CERT Open CERT document View SEC filing for CERT 24 Oct 2024 001-42383
EFFECT Open EFFECT document View SEC filing for EFFECT 23 Oct 2024 333-282508
3 Open 3 document View SEC filing for 3 3 23 Oct 2024 23 Oct 2024
3 Open 3 document View SEC filing for 3 3 23 Oct 2024 23 Oct 2024
3 Open 3 document View SEC filing for 3 3 23 Oct 2024 23 Oct 2024
3 Open 3 document View SEC filing for 3 3 23 Oct 2024 23 Oct 2024
3 Open 3 document View SEC filing for 3 3 23 Oct 2024 23 Oct 2024
3 Open 3 document View SEC filing for 3 3 23 Oct 2024 23 Oct 2024
3 Open 3 document View SEC filing for 3 3 23 Oct 2024 23 Oct 2024
3 Open 3 document View SEC filing for 3 3 23 Oct 2024 23 Oct 2024
8-A12B Open 8-A12B document View SEC filing for 8-A12B 8-A12B 23 Oct 2024 001-42383
CORRESP Open CORRESP document View SEC filing for CORRESP 21 Oct 2024
CORRESP Open CORRESP document View SEC filing for CORRESP 21 Oct 2024
CORRESP Open CORRESP document View SEC filing for CORRESP 18 Oct 2024
S-1/A Open S-1/A document View SEC filing for S-1/A S-1/A 18 Oct 2024 333-282508
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 18 Oct 2024 377-07367
CORRESP Open CORRESP document View SEC filing for CORRESP 04 Oct 2024
S-1 Open S-1 document View SEC filing for S-1 S-1 04 Oct 2024 333-282508
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 01 Oct 2024 377-07367
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 13 Sep 2024
DRS/A Open DRS/A document View SEC filing for DRS/A 13 Sep 2024 377-07367
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 05 Sep 2024 377-07367
DRS Open DRS document View SEC filing for DRS 07 Aug 2024 377-07367

About this filer

Oaktree Acquisition Corp. III Life Sciences files with the SEC under CIK 0002029769. This page aggregates EDGAR filings and related ownership activity.

Industry: Blank Checks.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .